Drug Shortage Report for SEVOFLURANE
| Report ID | 236909 |
| Drug Identification Number | 02265974 |
| Brand name | SEVOFLURANE |
| Common or Proper name | SEVOFLURANE |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | SEVOFLURANE |
| Strength(s) | 99.97% |
| Dosage form(s) | LIQUID |
| Route of administration | INHALATION INHALATION |
| Packaging size | 250 mL |
| ATC code | N01AB |
| ATC description | ANESTHETICS, GENERAL |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-09-06 |
| Actual start date | 2024-09-06 |
| Estimated end date | 2024-10-22 |
| Actual end date | 2024-10-22 |
| Shortage status | Resolved |
| Updated date | 2024-10-23 |
| Company comments | For questions or concerns contact Baxter customer care (1.888.719.9955) or your local Baxter representative. CA2L9117SV (Fused Bottle with integrated Safe-T-Seal Adaptor) is available as an alternative. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-10-23 | English | Compare |
| v5 | 2024-10-22 | French | Compare |
| v4 | 2024-10-22 | English | Compare |
| v3 | 2024-09-07 | English | Compare |
| v2 | 2024-09-06 | French | Compare |
| v1 | 2024-09-06 | English | Compare |
Showing 1 to 6 of 6